Zdrowie i gospodarka · 22/11/2017

FDA Releases Guidance for Evaluating Abuse Deterrence of Generic Solid Oral Opioid Drug Products

The FDA has announced a new guidance to help generic drug manufacturers demonstrate that their products are no less abuse-deterrent than their reference listed counterparts, in order to gain FDA approval.